Inter-alpha-inhibitor binding to hyaluronan in the cumulus extracellular matrix is required for optimal ovulation and development of mouse oocytes.
This report characterizes the effects of excess hyaluronan (HA) upon the expansion of the cumulus oocyte complex (COC) within intact follicles and upon ovulation and oocyte viability in mice. Covalent linkage between heavy chains of the inter-alpha-inhibitor (IalphaI) family of serum glycoproteins and HA is necessary for optimal cumulus extracellular matrix (cECM) stabilization and cumulus expansion. Intravenous administration of HA oligosaccharides inhibited the binding of IalphaI to endogenous HA, disrupting the process of expansion and resulting in a reduction in the size of the cumulus mass. Western blot and immunocytochemical analyses of COCs from HA-treated animals demonstrated a reduction of IalphaI heavy chains within the cECM. Additionally, HA-treated immature animals ovulated 56.3% fewer COCs compared to control animals. The developmental potential of COCs in HA-treated animals was also tested. Extended periods of oviductal storage of COCs ovulated by HA-injected adult mice resulted in a reduction of normal embryos and a significant increase in the proportion of fragmented oocytes/embryos. These observations support the view that covalent binding of IalphaI heavy chains to HA is required for optimal cumulus expansion, extrusion of the COCs from the follicle at ovulation, and maintenance of oocyte viability within the oviduct.
Hess
K A
KA
Molecular and Developmental Biology, Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0521, USA.
Chen
L
L
Larsen
W J
WJ
D000510:Alpha-Globulins / Q000378:metabolism*; D000818:Animals; D015153:Blotting, Western; D002470:Cell Survival; D005109:Extracellular Matrix / Q000378:metabolism*; D005260:Female; D006820:Hyaluronic Acid / Q000378:metabolism*; D008297:Male; D051379:Mice; D008970:Molecular Weight; D009865:Oocytes / Q000254:growth & development*; D010060:Ovulation; D015842:Serine Proteinase Inhibitors / Q000378:metabolism*; D014783:Viscosity
D000510:Alpha-Globulins; D015842:Serine Proteinase Inhibitors; C011877:inter-alpha-inhibitor; D006820:Hyaluronic Acid